High Volume Breakouts: These Four Stocks May Surge 25–30% In Coming Months, Says SEBI RA Vinay Taparia

Midcap stocks like Strides Pharma and Zuari Industries are showing strong uptrend potential. Price action and RSI indicators suggest multi-month rallies, according to the analyst.
Financial market volatility on digital interface with fluctuating trading data real-time stock market analysis and investment trends. (Stock picture/Getty Images)
Financial market volatility on digital interface with fluctuating trading data real-time stock market analysis and investment trends. (Stock picture/Getty Images)
Profile Image
Preeti Ayyathurai·Stocktwits
Published Jul 29, 2025 | 11:18 PM GMT-04
Share this article

Four midcap stocks have caught SEBI-registered analyst Vinay Taparia’s attention after giving high-volume breakouts on the charts, signaling potential multi-month rallies.

Strides Pharma, Zuari Industries, Gateway Distriparks, and Apcotex Industries are showing bullish technical setups, with upside potential of 25% to 30%. But Taparia cautions that any close below key support levels could invalidate this outlook.

Let’s take a look at his recommendations:

Strides Pharma Science

Strides Pharma has made new highs with huge volumes. The stock can move to the ₹1,200 level in the next 12 months. But a close below ₹895 invalidates this outlook.

Zuari Industries

Zuari has given a good breakout with huge volumes. The stock can move to ₹340-₹380 in the next six to twelve months, but a close below ₹260 negates this view.

Gateway Distriparks

Gateway Distriparks has broken out of base with huge volume. Its Relative Strength Index (RSI) is also showing strength. The stock can go to the ₹82-₹90 level in the next nine to twelve months. A close below ₹63 negates this view.

Apcotex Industries

Apcotex gave a good breakout with huge volume. RSI is above 70. The stock can move to ₹470-₹540 in nine to twelve months. A close below ₹380 negates this view. 

Subscribe to The Daily Rip India
All Newsletters
The most relevant Indian markets intel delivered to you everyday.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Read about our editorial guidelines and ethics policy